Scion Asset Management, founded by Michael Burry of "Big Short" fame, started new positions in consumer and healthcare names including lululemon athletica (LULU ...

Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...

Acquisition sends thousands of Whistle pet trackers to IoT graveyard Whistle pet monitors will stop working on August 31.

Baker Hughes is reportedly preparing a $13.6 billion cash acquisition of Chart Industries, threatening its pending $19 billion merger with Flowserve.

Seattle Mariners Major Trade Acquisition Makes Franchise History in 4th Game With Team All-Star first baseman Josh Naylor has quickly made a good impression with his new club.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord updated estimates on Regeneron Pharmaceuticals, Inc.

A trade association that represents cloud providers in the European Union has filed suit over Broadcom Inc.’s acquisition of VMware. The group, CISPE, disclosed the move today. It submitted the ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Sponsored Insights Why cyber modernization requires partners with technical plus acquisition expertise Navigating the rapid pace of technology within procurement constraints requires experts who ...

A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...

Shares of Regeneron Pharmaceuticals Inc. REGN slipped 1.36% to $542.52 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0. ...

Great CX is in reach and changing the dynamics in the competitive world of merchant acquisition.